Brain Neurons: Energy & Temperature Control
- New research from Pennington Biomedical Research Centre provides insights into how specific brain regions and neurons govern metabolism, body temperature, and energy use.
- Prior work by Münzberg-Gruening's team established that leptin receptors (Lepr) regulate leptin's metabolic effects.
- The research showed that neurons signaling to the raphe pallidus, a brain region controlling metabolism, exclusively use glutamate.Conversely, neurons signaling to the arcuate nucleus, which regulates body weight,...
Uncover groundbreaking research on how brain neurons control energy use, body temperature, and metabolism. This study from Pennington Biomedical Research Center identifies key chemicals and pathways influencing the body’s energy consumption. explore the critical role of leptin receptors (Lepr) within the dorsomedial hypothalamus (DMH) and how they communicate via glutamate and GABA signals. These findings could pave the way for new weight loss medications. News Directory 3 reports on the neuronal interplay that dictates energy usage and adaptation to temperature changes. Learn how specific signals impact metabolic processes and perhaps explain why GLP-1 medications work effectively. The research clarifies how neurons signal the raphe pallidus and the arcuate nucleus, showcasing the complexities of the brain’s impact on energy balance. Discover what’s next in the quest to understand and potentially manipulate metabolic functions.
Brain Neurons Impact Metabolism, Energy Use, and Body Temperature
New research from Pennington Biomedical Research Centre provides insights into how specific brain regions and neurons govern metabolism, body temperature, and energy use. The study, featured in Metabolism, identifies chemicals influencing signals that dictate the body’s energy consumption. Dr. Heike Münzberg-Gruening led the team that pinpointed pathways, chemicals, neurons, and activated brain regions.
Prior work by Münzberg-Gruening’s team established that leptin receptors (Lepr) regulate leptin’s metabolic effects. These receptors are neurons within the dorsomedial hypothalamus (DMH), a nucleus at the brain’s base. The latest study reveals that Lepr neurons communicate via two chemical signals: glutamate, which stimulates neurons, and GABA, which calms them. Understanding the role of these neurons may help in the development of new weight loss medications.
The research showed that neurons signaling to the raphe pallidus, a brain region controlling metabolism, exclusively use glutamate.Conversely, neurons signaling to the arcuate nucleus, which regulates body weight, satiety, and metabolism, use only GABA. These GABA neurons also possess receptors responsive to GLP-1 receptor agonists, a class of weight-loss drugs.this research highlights the importance of leptin signaling in the DMH to promote beneficial metabolic effects.
“This revelation sheds light on the basic neuronal interplay that influences how much energy the body uses and how the body adjusts to changes in temperature levels or food availability,” said Dr. Münzberg, professor in Pennington Biomedical’s Central Leptin Signaling Lab.
The study also found that some Lepr neurons are muted by leptin, while others activate when specific indirect signals are blocked. This suggests the DMH is part of a broader neuronal network. Leptin amplifies the muting effect of external connections to the DMH, but blocking these connections allows leptin to un-mute DMH neurons. These networks may integrate and override environmental signals to properly adapt body energy balance. This research expands our knowledge of thermoregulation and emphasizes the unique capability of leptin signaling in the DMH to promote beneficial metabolic effects. It also clarifies leptin signaling’s role in the stability of body weight and energy usage.
The findings clarify that Lepr neurons are a distinct subset of DMH neurons promoting metabolic benefits. They might explain why GLP-1-based medications can override the slowed metabolism often associated with weight loss, though further research is needed.
what’s next
Future studies will further investigate the paradox of how GLP-1 medications override the slow metabolism associated with weight loss, possibly leading to new strategies for managing metabolism and obesity.